Geron Corporation
NASDAQ · us_market
No AI insight generated yet for this ticker.
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. The company's product pipeline includes RYTELO, a telomerase inhibitor for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia; IMerge which is in Phase 3 clinical trial for the treatment of lower-risk myelodysplastic syndromes; IMpactMF that is in Phase 3 for the treatment of relapsed/refractory myelofibrosis; Impress which is in Phase 2 clinical trial to treat higher risk myelodysplastic syndromes and acute myeloid leukemia (AML); IMproveMF which is in Phase 1 clinical trial for the treatment of frontline myelofibrosis; and IMAGINE which is in phase 1/2 clinical trial for the treatment of relapsed/refractory AML. Geron Corporation was incorporated in 1990 and is headquartered in Foster City, California.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| StateStreet | passive | 30.50M | $45.44M | 0.00% | Added+13.5% | 2026-03-31 |
| Citadel | multi-strat | 20.46M | $30.48M | 0.04% | New | 2026-03-31 |
| FidelityFMR | fundamental | 6.60M | $9.83M | 0.00% | Trimmed-18.3% | 2026-03-31 |
| TwoSigma | quant | 1.89M | $2.82M | 0.00% | Trimmed-32.6% | 2026-03-31 |
| RenTech | quant | 1.80M | $2.68M | 0.00% | Added+144.1% | 2026-03-31 |
| TRowePrice | fundamental | 390.0K | $582 | 0.00% | Added+25.0% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-05upcoming | -0.01 | — | — |
| 2026-05-06 | -0.02 | — | +75.50% |
| 2026-02-25 | -0.04 | -0.02 | +52.89% |
| 2025-11-05 | -0.03 | -0.03 | +12.51% |
| 2025-08-06 | -0.03 | -0.02 | +39.02% |
| 2025-05-07 | -0.04 | -0.03 | +15.90% |
| 2025-02-26 | -0.02 | -0.04 | -86.65% |
| 2024-11-07 | -0.08 | -0.04 | +50.09% |
| 2024-08-08 | -0.10 | -0.10 | +1.57% |
| 2024-05-02 | -0.09 | -0.09 | +3.57% |
| 2024-02-28 | -0.10 | -0.09 | +10.00% |
| 2023-11-02 | -0.10 | -0.08 | +18.64% |
| 2023-08-03 | -0.08 | -0.09 | -8.00% |
| 2023-05-11 | -0.10 | -0.07 | +31.37% |
| 2023-03-16 | -0.12 | -0.10 | +18.92% |
| 2022-11-03 | -0.09 | -0.10 | -7.15% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| GERN | -20.89% | -13.19% | -5.30% | -17.76% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | -23.86% | -8.56% | -1.86% | -30.45% |